Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Oric Pharmaceuticals, Inc. market cap for the quarter ending 2026-07-27 was $1.24B, a 28.30% increase year-over-year.
Oric Pharmaceuticals, Inc. market cap for the quarter ending 2026-06-30 was $1.12B, a 28.36% increase year-over-year.
Oric Pharmaceuticals, Inc. market cap for the quarter ending 2026-04-27 was $1.06B, a 192.10% increase year-over-year.
Oric Pharmaceuticals, Inc. market cap for the quarter ending 2026-03-31 was $1.31B, a 230.07% increase year-over-year.
Oric Pharmaceuticals, Inc. market cap for fiscal 2026 was $1.24B.
Oric Pharmaceuticals, Inc. market cap for fiscal 2025 was $806.46M, a 40.71% increase from fiscal 2024.
Oric Pharmaceuticals, Inc. market cap for fiscal 2024 was $573.15M, a 13.55% increase from fiscal 2023.
Oric Pharmaceuticals, Inc. market cap for fiscal 2023 was $504.76M, a 90.06% increase from fiscal 2022.